Literature DB >> 32816134

Association between circulating tumor necrosis factor receptors and oral bacterium in patients receiving hemodialysis: a cross-sectional study.

Risako Mikami1, Koji Mizutani1, Tomohito Gohda2, Hiromichi Gotoh3, Yusuke Matsuyama4, Norio Aoyama5, Takanori Matsuura1, Daisuke Kido1, Kohei Takeda1, Yuichi Izumi1,6, Takeo Fujiwara4, Takanori Iwata1.   

Abstract

BACKGROUND: High levels of tumor necrosis factor (TNF) receptors (TNFRs; TNFR1 and TNFR2), markers of inflammation, have been reported as significant predictors of mortality in hemodialysis patients. Porphyromonas gingivalis is a major pathogenic bacterium involved in periodontitis, which induces systemic inflammation. We investigated the association between the abundance of P. gingivalis in saliva and serum TNFR levels in hemodialysis patients.
METHODS: A cross-sectional study was conducted on 121 hemodialysis patients visiting a clinic in the Tokyo metropolitan area. Medical interviews and examinations, comprehensive dental examinations, bacterial examinations for P. gingivalis in saliva, and measurements of circulating TNFR levels were conducted. Multiple linear regression analysis was performed to evaluate the association between the number of P. gingivalis and circulating TNFR levels.
RESULTS: TNFR1 and TNFR2 were positively correlated with high-sensitivity C-reactive protein (hsCRP). Severe periodontitis was significantly associated with the number of P. gingivalis in saliva but not serum TNFR levels. The number of P. gingivalis was significantly associated with both TNFR1 and TNFR2 levels in sera after adjusting for age, sex, body mass index, smoking status, history of diabetes, prior cardiovascular disease events, serum levels of hsCRP and albumin, and severity of periodontitis [for TNFR1: coefficient 0.76, 95% confidence interval (CI) 0.14-1.37, p = 0.02; for TNFR2: coefficient 0.95, 95% CI 0.09-1.80, p = 0.03].
CONCLUSION: Circulating TNFR levels are associated with the number of P. gingivalis in saliva after adjusting for relevant clinical factors.

Entities:  

Keywords:  Chronic kidney disease; Hemodialysis; P. gingivalis; Periodontitis; TNF receptor

Year:  2020        PMID: 32816134     DOI: 10.1007/s10157-020-01952-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  37 in total

Review 1.  Hemodialysis.

Authors:  Jonathan Himmelfarb; T Alp Ikizler
Journal:  N Engl J Med       Date:  2010-11-04       Impact factor: 91.245

Review 2.  Tumor necrosis factor superfamily molecules in acute coronary syndromes.

Authors:  Pål Aukrust; Wiggo J Sandberg; Kari Otterdal; Leif E Vinge; Lars Gullestad; Arne Yndestad; Bente Halvorsen; Thor Ueland
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

3.  Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality.

Authors:  Shilpa Sharma; Mark J Sarnak
Journal:  Nat Rev Nephrol       Date:  2017-06-19       Impact factor: 28.314

4.  Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes - findings from two community based cohorts of elderly.

Authors:  Axel C Carlsson; C Christofer Juhlin; Tobias E Larsson; Anders Larsson; Erik Ingelsson; Johan Sundström; Lars Lind; Johan Arnlöv
Journal:  Atherosclerosis       Date:  2014-09-16       Impact factor: 5.162

5.  Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

Authors:  Tomohito Gohda; Monika A Niewczas; Linda H Ficociello; William H Walker; Jan Skupien; Florencia Rosetti; Xavier Cullere; Amanda C Johnson; Gordon Crabtree; Adam M Smiles; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

Review 6.  Risk factors for mortality in patients undergoing hemodialysis: A systematic review and meta-analysis.

Authors:  Lijie Ma; Sumei Zhao
Journal:  Int J Cardiol       Date:  2017-02-22       Impact factor: 4.164

7.  Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy.

Authors:  Maki Murakoshi; Tomohito Gohda; Yuji Sonoda; Hitoshi Suzuki; Yasuhiko Tomino; Satoshi Horikoshi; Yusuke Suzuki
Journal:  Clin Exp Nephrol       Date:  2017-04-07       Impact factor: 2.801

8.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 9.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

10.  Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals.

Authors:  Axel C Carlsson; Lina Nordquist; Tobias E Larsson; Juan-Jesús Carrero; Anders Larsson; Lars Lind; Johan Ärnlöv
Journal:  Cardiorenal Med       Date:  2015-07-31       Impact factor: 2.041

View more
  3 in total

1.  Poor oral hygiene and dental caries predict high mortality rate in hemodialysis: a 3-year cohort study.

Authors:  Koji Mizutani; Risako Mikami; Tomohito Gohda; Hiromichi Gotoh; Norio Aoyama; Takanori Matsuura; Daisuke Kido; Kohei Takeda; Yuichi Izumi; Yoshiyuki Sasaki; Takanori Iwata
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

2.  Association of type 2 diabetes with periodontitis and tooth loss in patients undergoing hemodialysis.

Authors:  Risako Mikami; Koji Mizutani; Yusuke Matsuyama; Tomohito Gohda; Hiromichi Gotoh; Norio Aoyama; Takanori Matsuura; Daisuke Kido; Kohei Takeda; Natsumi Saito; Takeo Fujiwara; Yuichi Izumi; Takanori Iwata
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.240

3.  Association Between Kidney Function Decline and Baseline TNFR Levels or Change Ratio in TNFR by Febuxostat Chiefly in Non-diabetic CKD Patients With Asymptomatic Hyperuricemia.

Authors:  Tomohito Gohda; Naotake Yanagisawa; Maki Murakoshi; Seiji Ueda; Yuji Nishizaki; Shuko Nojiri; Yasuo Ohashi; Iwao Ohno; Yugo Shibagaki; Naohiko Imai; Satoshi Iimuro; Masanari Kuwabara; Hiroshi Hayakawa; Kenjiro Kimura; Tatsuo Hosoya; Yusuke Suzuki
Journal:  Front Med (Lausanne)       Date:  2021-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.